Statistics for Monte Rosa Therapeutics, (id:8159 GLUE)

Valuation metrics

Market cap

521.60M

Enterprise value

314.50M

Trailing P/E (ttm)

-3.23

Forward P/E

-5.66

PEG ratio

-5.66

Price/Sales (ttm)

34.83

Price/Book (mrq)

2.54

Enterprise Value/Revenue

21.00

Enterprise Value/EBITDA

-2.60

Overview

Shares outstanding

61.44M

Float

38.21M

Shares short

7.84M

% Held by insiders

0.01%

% Held by institutions

0.91%

Average volume (10 days)

989.17K

Average volume (90 days)

Price summary

52-Week low

2.91

52-Week high

12.40

52-Week change

64.66%

Beta

1.30

50-Day moving average

6.70

200-Day moving average

5.63

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-287.84%

Operational effectiveness

Return on assets

-28.42%

Return on equity

-61.23%

Income statement

Revenue (ttm)

0.22

Revenue per share (ttm)

0.22

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-121,073,000.00

Net income to common (ttm)

-119,389,000.00

Diluted EPS (ttm)

-1.78

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

242.19M

Total cash per share (mrq)

3.94

Total debt (mrq)

43.70M

Total Debt/Equity (mrq)

21.27

Current ratio (mrq)

603.30%

Book value per share (mrq)

3.35

Cash flow

Cash flow statement

-57,292,000.00

Levered free cash flow (LFCF)

-47,188,876.00